Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA9 | Q16790 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10792995 | 0.95 | TSHR (0.46) | TSHRCA12CA1CA9CA2 | |
| SCHEMBL23477341 | 0.95 | TSHR (0.46) | TSHRCA12CA1CA9CA2 | |
| SCHEMBL896509 | 0.92 | TSHR (0.48) | TSHRCA12CA1CA9CA2 | |
| SCHEMBL3341604 | 0.89 | — | — | |
| SCHEMBL10793051 | 0.89 | DNM1 (0.48) | TSHRCA12CA1CA9CA2 | |
| SCHEMBL11416179 | 0.89 | DNM1 (0.48) | TSHRCA12CA1CA9CA2 | |
| SCHEMBL11554162 | 0.89 | DNM1 (0.48) | TSHRCA12CA1CA9CA2 | |
| SCHEMBL4732004 | 0.88 | CA12 (0.40) | TSHRCA12CA1CA9CA2 | |
| SCHEMBL15630544 | 0.88 | ALDH1A1 (0.43) | TSHRCA12CA1CA9CA2 | |
| SCHEMBL870314 | 0.86 | SMN1; SMN2 (0.46) | TSHRCA12CA1CA9CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027008-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING ACTIVATED CARBON OR A DERIVATIVE THEREOF | CSP TECHNOLOGIES, INC. | 2026-01-29 | — | — | US | claimed |
| US-20260014284-A1 | PROCESS FOR PREPARATION OF RADIOLABELED STYRYLPYRIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF | JUBILANT DRAXIMAGE INC (CA) | 2026-01-15 | — | — | US | claimed |
| EP-4037679-B1 | A PROCESS FOR THE PREPARATION OF HIGHLY PURE VALSARTAN | HARMAN FINOCHEM LTD (IN) | 2025-08-06 | — | — | EP | claimed |
| US-12365654-B2 | Process for the preparation of highly pure valsartan | HARMAN FINOCHEM LIMITED (IN) | 2025-07-22 | — | — | US | claimed |
| US-20250166651-A1 | METHOD FOR CONSTRUCTING TRANSVERSE AUDIBLE NOISE MODEL FOR AN ELECTRIC TRANSMISSION CORRIDOR, MICROPHONE SUPPORT APPARATUS, AND AUDIBLE NOISE MEASUREMENT DEVICE | GLOBAL ENERGY INTERCONNECTION RESEARCH INSTITUTE CO., LTD. (CN) | 2025-05-22 | — | — | US | claimed |
| CN-119936256-A | Method for simultaneously detecting 9 nitrosamines in medicinal infusion bag | 重庆市计量质量检测研究院 | 2025-05-06 | — | — | CN | claimed |
| CN-119269672-A | Extraction, separation and detection method for N-nitrosamine | 华南理工大学 | 2025-01-07 | — | — | CN | claimed |
| CN-119246753-A | Universal analysis and detection method for 7 nitrosamines in medicine | 上海合全药物研发有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-119224148-A | Detection method for determining nitrosamine compounds in cold medicine based on gas chromatography-tandem mass spectrometry | 绍兴市疾病预防控制中心 | 2024-12-31 | — | — | CN | claimed |
| EP-4470565-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | OnQuality Pharmaceuticals China Ltd. (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-104568562-A | Water sample and pretreatment method of nitrosoamine compound in suspended matter of water sample | UNIV CHINA GEOSCIENCES WUHAN | 2015-04-29 | — | — | CN | claimed |
| CN-104076106-A | Method suitable for simultaneously detecting 9 N-nitrosamines in food contact rubber products | INSPECTION AND QUARANTINE TECHNOLOGY CT ZHEJIANG ENTRY EXIT INSPECTION AND QUARANTINE BUREAU | 2014-10-01 | — | — | CN | claimed |
| US-20090324787-A2 | DEODORIZED PLANT COLORANT DERIVED FROM IPOMOEA BATATAS (as amended) | SAN-EI GEN F.F.I., INC. (JP) | 2009-12-31 | — | — | US | claimed |
| US-20090238932-A1 | Deodorized plant colorant derived from Ipomoea Batatas | SAN-EI GEN F.F.I., INC. (JP) | 2009-09-24 | — | — | US | claimed |
| EP-2096146-A1 | Deodorized plant pigment derived from Ipomoea Batatas | SAN-EI GEN F.F.I., INC. (JP) | 2009-09-02 | — | — | EP | claimed |
| US-4535154-A | ONE-STEP USING POTASSIUM HYDROXIDE AND A NICKEL-ALUMINUM CATALYST | UNITED STATES OF AMERICA (US) | 1985-08-13 | — | — | US | claimed |
| US-4197226-A | Water-soluble coating composition | NIPPON OIL CO., LTD. (JP) | 1980-04-08 | — | — | US | claimed |
| US-4171308-A | ADDUCT OF A BUTADIENE POLYMER AND AN A,B-UNSATURATED CARBOXY ACID COMPOUND, NEUTRALIZED | NIPPON OIL CO. LTD. (JP) | 1979-10-16 | — | — | US | claimed |
| US-4053317-A | N-NITROSO COMPOUND, PHOTOPOLYMERIZABLE COMPOUND | TEIJIN LIMITED (JA) | 1977-10-11 | — | — | US | claimed |
| US-3952023-A | Method for preparing adduct of butadiene polymer or copolymer and α, β-ethylenically unsaturated dicarboxylic acid compound | NIPPON OIL COMPANY LTD. (JA) | 1976-04-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12365654-B2 | Process for the preparation of highly pure valsartan | REN, AGT, ACE | TSHR 3820/4885CA12 3912/4885CA1 3646/4885 |
| US-20260014284-A1 | PROCESS FOR PREPARATION OF RADIOLABELED STYRYLPYRIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF | NEFM, APP, PSEN2 | TSHR 415/4885CA12 2581/4885CA1 2260/4885 |
| US-20260027008-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING ACTIVATED CARBON OR A DERIVATIVE THEREOF | NOS2, NOS1, NOS3 | TSHR 4461/4885CA12 3108/4885CA1 3461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.